There are several choices for investors interested in biotech exposure through an ETF. Data analysis shows that biotech ETF returns are more sensitive to timing than the S&P500 and have higher ...
Biotech sector has potential for outperformance in the next year. VanEck Biotech ETF is a good product to consider for exposure to the sector. BBH focuses on large-cap biotech stocks, offering a more ...
BOSTON--(BUSINESS WIRE)--Market volatility and a challenging economic climate have been met with substantial shifts in how and where ETF investors are allocating their capital, according to the ...
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. Passively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results